IntrinsicIntrinsic
← All summaries

EUDA Health Holdings Ltd

EUDA
Financials & Chart →

Business Summary

EUDA Health Holdings Limited (EUDA) is an early-stage healthcare-technology provider headquartered in Singapore, aiming to deliver high-quality, personalized, and affordable healthcare through its proprietary platform. The company's core business model revolves around integrating a full continuum of healthcare services with data analytics, leveraging Artificial Intelligence (AI) and Machine Learning (ML) for real-time actionable insights, accurate diagnoses, and business decisions. EUDA generates revenue primarily from medical services fees and property management service fees, with a mix of transactional and contractually recurring income. The company's primary customer segments include corporate clients and individual consumers, with a focus on a Business-to-Business-to-Consumer (B2B2C) model .

The company's product and service lines are broadly categorized into Medical Urgent Care and Property Management Services. Medical Urgent Care services are marketed to healthcare provider organizations in Singapore, offering assistance and medical evacuation, with revenue generated on a per-healthcare visit basis for specialty medical visits . Property Management Services, acquired through Super Gateway Group Limited (SGGL) in January 2020, involve managing shopping malls, business office buildings, and residential apartments, generating contractually recurring revenue from common area and security management services . From 2023 onwards, Property Management Services are categorized under the Home Care Service line and are intended to evolve into home-based medical services . Additionally, EUDA operates a Digital Health Marketplace (DHM) for consumer health and wellness products, including dietary supplements, skincare, and healthy snacks, powered by smart capabilities for product comparison and cost efficiency .

For the fiscal year ended December 31, 2022, EUDA reported total revenues of $9,840,709 , a decrease of 6.7% from $10,544,550 in the prior year. Gross profit decreased by 21.0% to $3,354,196 from $4,244,353 in 2021, with the overall gross profit percentage declining to 34.1% from 40.3% . The company incurred a net loss of $24,949,246 for 2022, a significant shift from a net income of $900,396 in 2021. Diluted EPS was $(2.07) for 2022, compared to $0.09 in 2021. As of December 31, 2022, EUDA had cash and restricted cash of $784,485 and a negative working capital deficit of $4.1 million . Total liabilities amounted to $29,136,071 .

Year-over-year, medical services revenue increased by 5.9% to $6,065,368 in 2022 from $5,728,189 in 2021, primarily due to an increased number of employees/patients from corporate clients utilizing specialty healthcare services . Product sales revenue significantly decreased by 95.7% to $11,046 from $257,841 , attributed to decreased demand for facial recognition and temperature measurement monitor systems as the COVID-19 pandemic eased . Property management services revenue decreased by 17.4% to $3,764,295 from $4,558,520 , mainly due to a reduction in the number of managed properties . Gross profit percentage for medical services decreased by 8.9% to 41.8% , while product sales gross profit percentage saw a substantial decrease of 472.9% to (437.7)% , and property management services gross profit percentage decreased by 4.3% to 23.1% .

Significant operational developments during the period include the consummation of a business combination on November 17, 2022, where 8i Acquisition 2 Corp. purchased all outstanding shares of EUDA Health Limited, resulting in EUDA becoming a wholly-owned subsidiary of the renamed EUDA Health Holdings Limited . In connection with this, convertible notes totaling $3,402,225 were issued in a private placement to advisors . The company also incurred a loss of approximately $12.9 million from a change in prepaid forward purchase liabilities due to a significant drop in stock price after the business combination . Additionally, an impairment loss on long-lived assets and goodwill of $1,139,016 was recognized, fully impairing the remaining balance of goodwill and intangible assets from the January 2020 acquisition of Super Gateway Group Limited .

Business Outlook

EUDA aims to continuously build towards a consumer-centric digital ecosystem to allow clients and patients access to quality healthcare while keeping costs affordable, incorporating AI and ML on its platform to implement relevant solutions across a wide variety of healthcare and homecare services . The company plans to expand its reach across Southeast Asia .

A major growth area for EUDA is the expansion of its service verticals. The company's roadmap includes developing Digital Pharmacy, Medical Tourism, Chronic Disease Management, Mental Health, Diagnostics and Monitoring, Marketplace, Fitness, Women's Health, Corporate & Individual Health Plans, and EUDA Society (Doctor's Insurance) . However, due to budgetary and financial issues during the first five months of 2023, the timeline for the development of these health verticals has been pushed back to the second quarter of 2024 at the earliest . The company believes its unique ecosystem-based business model, integrating a full continuum of healthcare services with data analytics, differentiates it from competitors .

Another key growth vector involves investing in digitalization and innovation for digital care capabilities. EUDA is continuously investing in AI technology to expand patient engagement, improve efficiencies, reduce care costs, and promote better care coordination . This includes an AI deployment for a patient-provider matching tool to boost efficiency and user experience . Continued investment in interoperability, including remote patient monitoring, advanced analytics, lab services, and home delivery of pharmaceuticals, is expected to expand use cases . Strategic partnerships with innovative companies are also planned to differentiate offerings and add new capabilities .

Operationally, EUDA plans to drive greater adoption among existing clients by expanding the populations to which it offers services and increasing adoption within Singapore . This involves continually increasing awareness and loyalty by adding new and complementary products and services, third-party connections, and strategic alliances . The company will use targeted patient and medical provider engagement campaigns, best practices training, and operational support to increase platform usage . EUDA is also building robust data repositories to strengthen predictive models and multi-channel marketing strategies .

Regarding its cost structure, EUDA's general and administrative expenses increased significantly in 2022, partly due to professional fees related to the Business Combination and a $2.8 million increase in provision for bad debt . The company also incurred a $5.2 million earnout payment . Research and development expenses decreased by approximately $0.1 million in 2022 as the existing platform matured . The company aims to achieve economies of scale and reduce total operating costs to achieve desirable profitability .

For capital allocation, EUDA will require additional funding through the sale of debt or equity securities to support its continuing operations and growth . In February 2023, an executive director provided a working capital loan of $128,750 . From January to May 2023, the former CEO loaned the company an aggregate of $500,700 . In May 2023, EUDA initiated efforts to raise up to $4,000,000 from the sale of ordinary shares at $1.00 per share , raising $940,000 from the sale of 940,000 shares between May 16 and May 22, 2023 . The company is in active discussions with underwriters for a potential convertible notes financing transaction, with a goal for completion in the fourth quarter of 2023 .

Management explicitly flagged several structural headwinds and execution risks. The digital health industry is relatively young and evolving, and slow development or lack of competitiveness could adversely affect business growth . The company's short operating history makes it difficult to assess success and predict challenges . EUDA relies on corporate clients for a significant portion of its revenue, and the loss of these clients would have a material adverse effect . The business is also susceptible to rapid technological changes and increasing competition . Foreign exchange risks exist due to operations in multiple countries . The company's growth depends on successful strategic relationships with third parties and partners, and disruptions could impair its business .

Geographic, regulatory, and macro factors identified as constraints include the evolving government regulations in the digital health industry, with failure to comply potentially leading to increased costs or adverse effects on operations . The company's ability to provide digital health offerings is dependent on individual jurisdictions' treatment of digital health under their laws, rules, and policies, which are subject to change and interpretation . The potential for an economic recession and uncertainty in financial markets, along with the impact of inflation and rising interest rates, may affect customer demand and financial performance .

Risk Factors

EUDA faces substantial risks, including non-compliance with Nasdaq's continued listing standards, which could lead to delisting and negative impacts on liquidity and stock price . The company's independent registered public accounting firm's report contains an explanatory paragraph expressing substantial doubt about its ability to continue as a "going concern" due to a negative working capital deficit of approximately $4.1 million , recurring losses, and negative cash flows from operations since 2020 . Material weaknesses in internal control over financial reporting were identified, including a lack of sufficient financial reporting and accounting personnel with U.S. GAAP knowledge and an inadequate mechanism to assess third-party specialists . The company will require additional funding, and there is no assurance that capital raising efforts will be successful or available on acceptable terms, potentially leading to significant dilution or restrictive covenants . EUDA relies heavily on corporate clients for revenue, and the loss of any key client could materially impact its business . The digital health industry is young and rapidly evolving, with significant technological change and increasing competition, which could render EUDA's services uncompetitive or obsolete . The company's success is highly dependent on maintaining and expanding a network of qualified providers and partners, and disruptions could adversely affect its business . Reliance on third-party technology services and internal systems for service delivery exposes EUDA to risks of failure or interruption, potentially leading to litigation, reputational harm, and loss of clients . The company does not hold any issued patents, relying on copyright, trademark, and trade secret laws, and failure to protect its intellectual property could adversely impact its business and financial performance . Inaccurate or incomplete data provided through its platform could damage its reputation and ability to attract clients . Security breaches of client data pose significant liabilities, reputational harm, and potential loss of sales and clients .

Management Priorities

Management's message to shareholders emphasizes EUDA's mission to make high-quality, personalized healthcare affordable and accessible through its proprietary platform, with a strategic focus on expanding across Southeast Asia . They highlight the integration of AI and ML to provide real-time actionable analytics for quick analysis, accurate diagnoses, and business decisions, aiming to deliver data-driven, personalized quality insights to patients . Management believes in incorporating technology into the traditional medical services market to create an end-to-end ecosystem offering a comprehensive suite of healthcare and wellness services . Key strategic priorities include continuously building a consumer-centric digital ecosystem, investing in digitalization and innovation for digital care capabilities, and leveraging existing sales channels to penetrate new medical provider markets . Management also stressed the importance of its "Always-On" approach, providing 24/7 concierge-level care coordination services for high-risk members, and strengthening capabilities through geographical presence and a wide network of medical partners . They acknowledge the need for additional funding to support continuing operations and growth initiatives, with plans for a potential convertible notes financing transaction in the fourth quarter of 2023 .

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business — Overview
  2. [2] Item 1, Business — Overview
  3. [3] Item 1, Business — Overview
  4. [4] Item 1, Business — EUDA's Solutions
  5. [5] Item 1, Business — Marketplace
  6. [6] Item 7, MD&A — Results of Operations
  7. [7] Item 7, MD&A — Revenues
  8. [8] Item 7, MD&A — Results of Operations
  9. [9] Item 7, MD&A — Gross Profit
  10. [10] Item 7, MD&A — Results of Operations
  11. [11] Item 7, MD&A — Results of Operations
  12. [12] Item 7, MD&A — Gross Profit
  13. [13] Item 7, MD&A — Gross Profit
  14. [14] Item 7, MD&A — Results of Operations
  15. [15] Item 7, MD&A — Results of Operations
  16. [16] Item 8, Consolidated Statements of Operations and Comprehensive Income (Loss)
  17. [17] Item 8, Consolidated Statements of Operations and Comprehensive Income (Loss)
  18. [18] Item 7, MD&A — Liquidity and Capital Resources
  19. [19] Item 7, MD&A — Liquidity and Capital Resources
  20. [20] Item 8, Consolidated Balance Sheets
  21. [21] Item 7, MD&A — Revenues
  22. [22] Item 7, MD&A — Revenues
  23. [23] Item 7, MD&A — Revenues
  24. [24] Item 7, MD&A — Medical services
  25. [25] Item 7, MD&A — Product sales
  26. [26] Item 7, MD&A — Revenues
  27. [27] Item 7, MD&A — Revenues
  28. [28] Item 7, MD&A — Product sales
  29. [29] Item 7, MD&A — Property management services
  30. [30] Item 7, MD&A — Revenues
  31. [31] Item 7, MD&A — Revenues
  32. [32] Item 7, MD&A — Property management services
  33. [33] Item 7, MD&A — Gross Profit
  34. [34] Item 7, MD&A — Gross Profit
  35. [35] Item 7, MD&A — Gross Profit
  36. [36] Item 7, MD&A — Gross Profit
  37. [37] Item 7, MD&A — Gross Profit
  38. [38] Item 7, MD&A — Gross Profit
  39. [39] Item 7, MD&A — Recent Development
  40. [40] Item 7, MD&A — Recent Development
  41. [41] Item 7, MD&A — Recent Development
  42. [42] Item 7, MD&A — Other(expenses) income, net
  43. [43] Item 7, MD&A — Change in prepaid forward purchase liabilities
  44. [44] Item 7, MD&A — Operating Expenses
  45. [45] Item 7, MD&A — Impairment loss on long-lived assets
  46. [46] Item 1, Business — Overview
  47. [47] Item 1, Business — Overview
  48. [48] Item 1, Business — Competitive Strengths
  49. [49] Item 1, Business — Competitive Strengths
  50. [50] Item 1, Business — Competitive Strengths
  51. [51] Item 7, MD&A — Investment in Digitalization and Innovation for Digital Care Capabilities
  52. [52] Item 7, MD&A — Investment in Digitalization and Innovation for Digital Care Capabilities
  53. [53] Item 7, MD&A — Investment in Digitalization and Innovation for Digital Care Capabilities
  54. [54] Item 7, MD&A — Investment in Digitalization and Innovation for Digital Care Capabilities
  55. [55] Item 1, Business — EUDA's Growth Strategy
  56. [56] Item 1, Business — EUDA's Growth Strategy
  57. [57] Item 1, Business — EUDA's Growth Strategy
  58. [58] Item 1, Business — EUDA's Growth Strategy
  59. [59] Item 7, MD&A — Operating Expenses
  60. [60] Item 7, MD&A — Operating Expenses
  61. [61] Item 7, MD&A — Operating Expenses
  62. [62] Item 7, MD&A — Operating Expenses
  63. [63] Item 7, MD&A — Operating Expenses
  64. [64] Item 7, MD&A — Operating Expenses
  65. [65] Item 1A, Risk Factors — Business and Operational
  66. [66] Item 1A, Risk Factors — Summary Risk Factors
  67. [67] Item 7, MD&A — Liquidity and Capital Resources
  68. [68] Item 7, MD&A — Liquidity and Capital Resources
  69. [69] Item 1A, Risk Factors — EUDA will require additional funding through sale of either debt or equity securities to support its continuing operations and growth of business, and such funding may not be available on acceptable terms, or at all, and that may adversely impact EUDA’s business, financial condition, results of operations and growth potential.
  70. [70] Item 7, MD&A — Liquidity and Capital Resources
  71. [71] Item 7, MD&A — Liquidity and Capital Resources
  72. [72] Item 7, MD&A — Liquidity and Capital Resources
  73. [73] Item 7, MD&A — Liquidity and Capital Resources
  74. [74] Item 7, MD&A — Liquidity and Capital Resources
  75. [75] Item 1A, Risk Factors — The digital health industry is relatively young, is currently in its early growth stages and is still evolving, and if it develops towards a mature stage more slowly than EUDA expects, if it encounters a pessimistic outlook or if EUDA’s services are not competitive, the growth of EUDA’s business will be adversely affected.
  76. [76] Item 1A, Risk Factors — EUDA’s short operating history and the rapidly evolving nature of the industry make it difficult to assess the Company’s success and predict the risks and challenges it may encounter.
  77. [77] Item 1A, Risk Factors — EUDA relies on its corporate clients for a significant portion of its revenue, the loss of which would have a material adverse effect on EUDA’s business, financial condition, and results of operations.
  78. [78] Item 1A, Risk Factors — The digital healthcare industry faces significant risks and challenges from rapid technological changes.
  79. [79] Item 1A, Risk Factors — There is foreign exchange (FX) risk in EUDA’s business as we operate in multiple countries and exchange rates fluctuate, and that may cause FX-related losses or translation losses for the Company.
  80. [80] Item 1A, Risk Factors — EUDA’s growth depends on the success of the Company’s strategic relationships with third parties and partners.
  81. [81] Item 1A, Risk Factors — The digital health industry faces evolving government regulations, and failure to comply with these changes may result in increased costs or adversely affect the Company’s results of operations.
  82. [82] Item 1A, Risk Factors — The digital health services EUDA offers are subject to laws, rules and policies governing the practice of medicine and relevant medical council oversight.
  83. [83] Item 7, MD&A — Liquidity and Capital Resources
  84. [84] Item 1A, Risk Factors — We are not currently in compliance with the continued listing standards of Nasdaq and may not be able to regain compliance with Nasdaq’s continued listing standards in the future.
  85. [85] Item 1A, Risk Factors — Our independent registered public accounting firm’s report contains an explanatory paragraph that expresses substantial doubt about our ability continue as a “going concern.”
  86. [86] Item 1A, Risk Factors — Our independent registered public accounting firm’s report contains an explanatory paragraph that expresses substantial doubt about our ability continue as a “going concern.”
  87. [87] Item 1A, Risk Factors — EUDA previously identified material weaknesses in the Company’s internal control over financial reporting, and if EUDA is unable to achieve and maintain effective internal control over financial reporting, this could have a material adverse effect on our business.
  88. [88] Item 1A, Risk Factors — EUDA will require additional funding through sale of either debt or equity securities to support its continuing operations and growth of business, and such funding may not be available on acceptable terms, or at all, and that may adversely impact EUDA’s business, financial condition, results of operations and growth potential.
  89. [89] Item 1A, Risk Factors — EUDA relies on its corporate clients for a significant portion of its revenue, the loss of which would have a material adverse effect on EUDA’s business, financial condition, and results of operations.
  90. [90] Item 1A, Risk Factors — The digital healthcare industry faces significant risks and challenges from rapid technological changes.
  91. [91] Item 1A, Risk Factors — EUDA’s business and growth strategy depends on its ability to maintain and expand a network of qualified providers and partners.
  92. [92] Item 1A, Risk Factors — EUDA relies heavily on technology services provided by third parties and its own systems for providing services to clients and members, and any failure or interruption in these services could expose the Company to litigation and negatively impact relationships with clients, its reputation, brand and business.
  93. [93] Item 1A, Risk Factors — EUDA currently does not hold any issued patents. EUDA’s financial and operational success depends highly on the Company’s ability to protect the Company’s intellectual property and intellectual property rights and failure to do so will adversely impact the Company’s business and financial performance.
  94. [94] Item 1A, Risk Factors — Inaccurate or incomplete information and data provided to EUDA’s clients through the Company’s platform could adversely impact the Company’s business reputation, financial condition, and results of operations.
  95. [95] Item 1A, Risk Factors — If EUDA’s security measures fail to ensure protection of clients’ data, services may be deemed insecure and as a result the Company could incur significant liabilities, reputational harm, and loss of sales and clients.
  96. [96] Item 1, Business — Overview
  97. [97] Item 1, Business — Overview
  98. [98] Item 1, Business — Overview
  99. [99] Item 1, Business — EUDA's Growth Strategy
  100. [100] Item 7, MD&A — Key Factors that Affect Operating Results
  101. [101] Item 7, MD&A — Liquidity and Capital Resources

Analysis on 5/21/2026